目錄:MedChemExpress LLC>>同位素標記物>> MMAF-d8 hydrochloride | MCE
純度 | 99.70% | 分子量 | 776.47 |
---|---|---|---|
分子式 | C??H??D?ClN?O? | 供貨周期 | 現貨 |
貨號 | HY-15579AS | 應用領域 | 醫療衛生,化工,生物產業,制藥 |
MCE 的所有產品僅用作科學研究或藥證申報,我們不為任何個人用途提供產品和服務。
產品活性:MMAF-d8 (hydrochloride)e是MMAF hydrochloride的氘代形式。
研究領域:Cytoskeleton | Cell Cycle/DNA Damage | Antibody-drug Conjugate/ADC Related
作用靶點:Microtubule/Tubulin | ADC Cytotoxin
In Vitro: MMAF shows in vitro cytotoxicity against a panel of cell lines. The IC50 values for Karpas 299, H3396, 786-O and Caki-1 are 119, 105, 257, and 200 nM, respectively. Targeted MMAF is much more potent than the free drug, and that cAC10 conjugates of MMAF display pronounced activities. On a molar basis, the cAC10-L1-MMAF4 is an average of over 2200-fold more potent than free MMAF and is active on all the CD30-positive cell lines tested.
In Vivo: The maximum tolerated dose in mice of MMAF (>16 mg/kg) is much higher than MMAE (1 mg/kg). cAC10-L1-MMAF4 has an MTD of 50 mg/kg in mice and 15 mg/kg in rats. The corresponding cAC10-L4-MMAF4 ADC was much less toxic, having MTDs in mice and rats of >150 mg/ kg and 90 mg/kg in rats, respectively.
相關產品:Tirbanibulin dihydrochloride | Tubulysin IM-3 | AMXI-5001 hydrochloride | Tubulin polymerization-IN-21 | Dolastatin 10 | (+)-CBI-CDPI1 | SB-216 | MAP4343 | Duocarmycin GA | Tubulin polymerization-IN-8 | Tubulysin IM-1 | Maytansinoid B | Colchicine-d3 | 2-Methoxyestradiol-13C,d3 | Taltobulin | Albendazole | Duocarmycin DM free base | Dideoxy-amanitin | Tilavonemab | DM4-d6 | Camptothecin | EGFR-IN-57 | Epothilone B | Epothilone A | Maytansinol | Maytansinoid DM4 | Docetaxel-d9 | N-Me-L-Ala-maytansinol | Duocarmycin A | Verubulin hydrochloride
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種*僅有化合物庫,我們致力于為*科研客戶提供前沿的高品質小分子活性化合物;
• 50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領;
• 產品種類涵蓋各種重組蛋白,多肽,常用試劑盒 ,更有 PROTAC、ADC 等特色產品,廣泛應用于新藥研發、生命科學等科研項目;
• 提供虛擬篩選,離子通道篩選,代謝組學分析檢測分析,藥物篩選等專業技術服務;
• 設有專業的實驗中心和嚴格的質控、驗證體系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質檢報告,確保產品的高純度、高品質;
• 產品的生物活性多經各國客戶實驗驗證;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果;
• 專業團隊跟蹤最新的制藥及生命科學研究進展,為您提供*新的活性化合物;
• 與世界各大制藥公司及著名科研機構建立了長期的合作。